AMGN

Diversifying by Sector: 20 High-Quality Attractive Dividend Growth Stocks Rated A- Or Better (Part 2B)

2018-11-08

Research Articles

Introduction This current series of articles could be summarized as a review of ways to construct and diversify a common stock portfolio.  In part 1 found here I discussed various viewpoints on how many stocks a portfolio should hold.  In Part 2A found here I presented and discussed Peter Lynch’s 6 general categories of stocks.  In […]

A Comprehensive Look At Dividend Growth Stock Valuations Sector By Sector: Part 2

2016-08-26

Research Articles

Introduction Finding attractively valued dividend growth stocks is getting harder and harder to do.  The overall market has been on a relentless advance for many years now, and high quality dividend paying growth stocks have been leaders.  Consequently, valuations have become extended beyond historical norms and I contend prudence.  Nevertheless, there are attractive dividend growth […]

5 Attractive Biotechnology Stocks for Healthy Long-term Returns

2016-06-10

Research Articles

Introduction I am a fervent believer that investors are best served by investing towards a specific investment objective that suits their own unique goals, objectives and risk tolerance.  In other words, investing is not always trying to get the highest possible total returns.  If that were true, no one would have ever invested in bonds, […]

Amgen’s Dividend Policy Has Ignited Their Stock

2013-01-11

Research Articles

Founded in 1980, Amgen (AMGN) is the world’s largest biotechnology company with a current market cap of just under $68 billion.  However, in spite of its already large size, we believe that Amgen has ample room to continue growing their earnings at above-average rates into the foreseeable future.  Our optimism for future growth is predicated […]

Five Healthy Dividend Growth Stocks to Cure What Ails Your Portfolio

2012-05-03

FAST Graphs At-A-Glance

These five above-average growing opportunities in the healthcare sector provide dividend growth investors potential alternatives to the traditional large-cap pharmaceuticals. This is a high quality group of healthcare companies that possess above-average growth potential plus an above-average dividend yield that is expected to grow at above-average future rates. Consequently, we believe these candidates offer the […]

Disclaimers: F.A.S.T. Graphs, Inc. is not a broker-dealer or a registered investment adviser. Under no circumstances does any information on Fastgraphs.com constitute a recommendation to buy or sell a security, nor does it give investment advice. This is to include any publications or articles on Fastgraphs.com. Fastgraphs.com is a research tool to be used by its subscribers in conjunction with the subscribers’ additional research and due diligence. The information on this site is in no way guaranteed for completeness or accuracy.